Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

DNA, Peptide Vaccines Advance Against GBM.

Cancer discovery·2026
Same journal

AKR1C1 Promotes ADC Resistance by Altering Uptake and Export.

Cancer discovery·2026
Same journal

Acquisition of Centromeric Features Supports Telomere Integrity.

Cancer discovery·2026
Same journal

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same journal

Type II JAK2 Inhibitor Gets Off to a Strong Start.

Cancer discovery·2026
Same journal

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026
See all related articles

Related Experiment Video

Updated: Nov 13, 2025

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

10.6K

New Single-Cell Screening Method Finds Immunotherapy Response Modulator

    Cancer Discovery
    |March 13, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Single-cell analysis revealed CD58 plays a key role in immune checkpoint blockade therapy. This finding offers new insights into enhancing cancer immunotherapy effectiveness.

    More Related Videos

    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
    08:49

    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

    Published on: January 22, 2019

    9.3K
    Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
    09:07

    Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

    Published on: August 22, 2019

    11.2K

    Related Experiment Videos

    Last Updated: Nov 13, 2025

    A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
    08:43

    A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

    Published on: March 10, 2017

    10.6K
    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
    08:49

    Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

    Published on: January 22, 2019

    9.3K
    Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
    09:07

    Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

    Published on: August 22, 2019

    11.2K

    Area of Science:

    • Immunology
    • Molecular Biology
    • Cancer Research

    Background:

    • Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment.
    • Understanding the molecular mechanisms that regulate ICB efficacy is crucial for improving patient outcomes.
    • Novel single-cell technologies are enabling deeper investigations into cellular interactions within the tumor microenvironment.

    Purpose of the Study:

    • To identify novel regulators of immune checkpoint blockade response using a high-throughput single-cell screening approach.
    • To elucidate the functional role of identified regulators in modulating anti-tumor immunity.

    Main Methods:

    • Utilized Perturb-CITE-seq, a single-cell multi-omic technology, to simultaneously profile gene expression and surface protein levels.
    • Performed high-throughput genetic screens in relevant immune cell populations.
    • Analyzed single-cell data to identify genes influencing immune checkpoint blockade sensitivity.

    Main Results:

    • Perturb-CITE-seq identified CD58 as a significant factor influencing the response to immune checkpoint blockade.
    • Functional validation demonstrated that CD58 expression levels correlate with T-cell activation and anti-tumor activity.
    • Downregulation of CD58 was associated with resistance to immune checkpoint blockade therapy.

    Conclusions:

    • CD58 is a critical mediator of immune checkpoint blockade efficacy.
    • Targeting CD58 may represent a promising strategy to enhance anti-tumor immunity and overcome resistance to current immunotherapies.
    • Further investigation into CD58's precise mechanisms of action is warranted.